BASF's Buyback Engine Meets Evonik Standoff as Ultrason Targets AI Data Centers

BASF repurchased 805,398 shares from Sept 28 to Oct 2, 2026, as its rejected EUR 22.15-per-share Evonik offer leaves capital priorities in question.

BASF is keeping two very different plates spinning at once: a steady stream of share repurchases that signals confidence in its own equity, and an audacious — so far rebuffed — approach for specialty chemicals rival Evonik. How management balances those priorities will shape the stock's trajectory well beyond the next few weeks.

The Ludwigshafen-based group disclosed that it bought back 805,398 of its own shares on the open market between September 28 and October 2, 2026. Since the current program launched on August 3, 2026, the cumulative volume has reached 5,830,987 shares. The ongoing purchases create a persistent source of demand for the stock while gradually shrinking the number of shares in circulation — a mechanical boost to earnings per share that requires no improvement in underlying operations.

That buyback message lands at a delicate moment. BASF is finalizing preparations for its interim report, even as the broader chemicals sector continues to grapple with volatile raw material costs and soft end markets.

A High-Stakes Tug-of-War Over Capital

The central question for investors is how BASF will deploy its financial firepower. On one side of the ledger, the relentless buyback demonstrates management's ability to act in shareholders' interests. On the other, a large-scale acquisition remains squarely in play.

Roughly a week ago, BASF confirmed exploratory talks with Evonik Industries AG and its major shareholder, the RAG-Stiftung, regarding a potential combination. Reuters reported that BASF had submitted an offer of about EUR 22.15 per Evonik share, valuing the target at roughly EUR 10.3 billion. Essen-based Evonik rejected the approach as too low and stressed that no discussions are currently underway. BASF declined to comment on the specific price.

That leaves shareholders weighing a difficult trade-off: Will BASF stick to a strict financial framework, or could a costly bidding war slow the pace of future buybacks?

Pricing Power and Portfolio Shifts Underpin the Core

In the optimistic scenario, management's operational countermeasures pay off quickly. BASF has shown it can pass higher costs through to customers in selected product lines. In North America, the company announced a price increase of USD 0.15 per pound for caprolactam, polyamide 6 and copolyamide, effective October 1 or as existing contracts allow. If those surcharges stick, operating margins in the plastics segment should stabilize.

At the same time, BASF is pushing ahead with its shift toward more sustainable materials. The company is broadening the application range of its Ultrason high-performance plastics portfolio specifically for electrical and electronic components, targeting artificial intelligence hardware in data centers, high-speed internet infrastructure and e-mobility applications. No concrete revenue or earnings targets were disclosed for the expanded segment, but the move underscores BASF's intent to capture global growth fields tied to digital infrastructure.

It follows a string of recent product initiatives. In late September, the group extended its Ultradur portfolio with post-consumer PET-based grades for engineering plastics. Before that, it introduced binders for paper coating colors with a reduced carbon footprint, which the company says is 20% to 45% below conventional products.

If BASF can occupy high-margin niches through such specialties while making its price increases stick, earnings power should remain resilient. Combined with the daily support from the buyback program, that would give the share price a stable foundation to defend its year-to-date gain of 13%.

The Costly Merger Scenario

The bear case, by contrast, stems from unresolved strategic questions. Should management decide to sweeten its Evonik offer substantially, the financial burden could be significant. A figure beyond EUR 10.3 billion would tie up considerable liquidity or push leverage noticeably higher. Investors fear that less capital would then remain for direct distributions.

Integrating a major corporation also carries lengthy execution risks, particularly when the target has so far rejected any rapprochement. If the advances fail outright or drag on without clear value creation, the strategic narrative fizzles out. And if lingering economic worries weigh on global demand for basic chemicals, even announced price hikes may fail to deliver the hoped-for earnings. In that scenario, selling pressure could build — something even the existing buyback program cannot fully cushion on its own.

Internal Restructuring Adds Another Layer

Alongside the materials innovations, BASF is pressing ahead with internal reorganizations. Roughly two weeks ago, the company announced a restructuring of its Agricultural Solutions division; since then, the stock has shed 4.0%. Leta LaRush took over leadership of the U.S. agricultural business on October 1, while the global realignment is set to take effect on January 1, 2027.

What the Charts and the Calendar Say

For the near-term trend, technical and operational resilience will be decisive. As long as the stock holds its 200-day moving average at EUR 49.69, the medium-term chart picture remains stable for existing positions. A slide below that closely watched line would suggest that skepticism over potential acquisition risks and the sector's economic cycle has gained the upper hand.

In pre-market trading on Tuesday, the stock was initially subdued, quoted at EUR 50.15 — a modest decline of 0.4%.

The next major catalyst is only weeks away. On October 28, 2026, at 7:00 a.m. CET, BASF will publish its full third-quarter 2026 report. That release will reveal how strong demand actually was during the summer months and whether management needs to adjust its annual targets. Until then, the debate over capital efficiency and the company's future expansion course is likely to dominate valuation. BASF currently carries a market capitalization of EUR 42.98 billion.